相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Investigating Potential Drug-Drug Interactions from Greek e-Prescription Data
Panagiotis-Nikolaos Lalagkas et al.
CURRENT DRUG SAFETY (2022)
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases
Eusebi Chiner-Vives et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2022)
Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
Marios Spanakis et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system
Ziyang Wu et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
Natasha Cordeiro Dos Santos et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2022)
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
Dario Cattaneo et al.
DRUGS & AGING (2021)
Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
Marios Spanakis et al.
PHARMACEUTICS (2021)
Hospital admission trends due to respiratory diseases in England and Wales between 1999 and 2019: an ecologic study
Abdallah Y. Naser et al.
BMC PULMONARY MEDICINE (2021)
Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments
Marios Spanakis et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
Heloisa Antoniella Braz-de-Melo et al.
FRONTIERS IN MEDICINE (2021)
Clinical characteristics and outcomes of polypharmacy in chronic obstructive pulmonary disease patients: A cross-sectional study from Crete, Greece
Despo Ierodiakonou et al.
CLINICAL RESPIRATORY JOURNAL (2021)
Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients
Marta Karazniewicz-Lada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain
M. D. Cantudo-Cuenca et al.
SCIENTIFIC REPORTS (2021)
Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic
Shiva Rattan Ambardar et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Managing drug-induced QT prolongation in clinical practice
Rani Khatib et al.
POSTGRADUATE MEDICAL JOURNAL (2021)
Polypharmacy: A general review of definitions, descriptions and determinants
Jordan Guillot et al.
THERAPIE (2020)
Risk factors for potential drug-drug interactions in patients with chronic obstructive pulmonary disease
Dobrivoje Stojadinovic et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2020)
Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease
Clarisse Roux-Marson et al.
BMC GERIATRICS (2020)
Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio
Marjorie Bernier et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Drug interactions for elderly with respiratory disorders and times of COVID-19: a systematic scoping review
Marcela Forgerini et al.
Vitae (2020)
Impact of Adverse Drug Reactions in Patients with End Stage Renal Disease in Greece
Marios Spanakis et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Interventions to reduce medication errors in adult medical and surgical settings: a systematic review
Elizabeth Manias et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2020)
Pharmacodynamic Drug-Drug Interactions
Jin Niu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2017
Jingjing Yu et al.
DRUG METABOLISM AND DISPOSITION (2019)
Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD
Jana Graf et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)
Examining patterns of multimorbidity polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
Peter Hanlon et al.
BMJ OPEN (2018)
High Prevalence of Drug-Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units
Marine L. Andersson et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
What is polypharmacy? A systematic review of definitions
Nashwa Masnoon et al.
BMC GERIATRICS (2017)
Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients
Luca Gallelli et al.
CURRENT DRUG SAFETY (2017)
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry
J. H. Salmon et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
Barbara Wisniowska et al.
BMC PHARMACOLOGY & TOXICOLOGY (2016)
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010
Bruce Guthrie et al.
BMC MEDICINE (2015)
Comorbidity as a driver of adverse outcomes in people with chronic kidney disease
Marcello Tonelli et al.
KIDNEY INTERNATIONAL (2015)
Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
Caroline Gjestad et al.
THERAPEUTIC DRUG MONITORING (2015)
Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease
Tina Roblek et al.
ARCHIVES OF MEDICAL SCIENCE (2014)
Drug-Induced Hyperkalemia
Chaker Ben Salem et al.
DRUG SAFETY (2014)
Polypharmacy in patients hospitalised for acute exacerbation of COPD
Jesus Diez-Manglano et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Meta-Analysis of Selective Serotonin Reuptake Inhibitor-Associated QTc Prolongation
Scott R. Beach et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis
Supinya Dechanont et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
Andreas Clemens et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used Medications
Alexandros Briasoulis et al.
CARDIOLOGY (2011)
Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece
Anna Chatsisvili et al.
PHARMACY WORLD & SCIENCE (2010)
Mechanisms of Drug Induced QT Interval Prolongation
Marcelo Luis Ponte et al.
CURRENT DRUG SAFETY (2010)
Frequency and nature of drug-drug interactions in a Dutch university hospital
Jeannette E. F. Zwart-van Rijkom et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Circos: An information aesthetic for comparative genomics
Martin Krzywinski et al.
GENOME RESEARCH (2009)
Drug-Induced Hypoglycemia: A Systematic Review
M. Hassan Murad et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Abatacept and serious respiratory infections in patients with previous lung disease
Karla L. Miller et al.
CLINICAL RHEUMATOLOGY (2008)
Risk factors for potential drug interactions in general practice
Lars Bjerrum et al.
European Journal of General Practice (2008)
Literature review and pilot studies of the effect of QT correction formulas on reported β2-agonist-induced QTc prolongation
Milos Milic et al.
CLINICAL THERAPEUTICS (2006)
Adverse drug reactions: definitions, diagnosis, and management
IR Edwards et al.
LANCET (2000)